中文摘要：

目的分析1990年与2013年中国人群肝癌疾病负担结果。方法利用2013年全球疾病负担研究结果，描述中国人群肝癌的疾病负担现状，主要指标包括死亡率、伤残调整寿命年（DALY）。同时，用2013年全球疾病负担研究的标准人口，计算标化死亡率、标化DALY率，并计算2013年与1990年的变化幅度，描述疾病负担指标的变化。结果2013年中国人群肝癌死亡总数约35．81万人，死亡率为25．85／10万，其中，继发于乙型肝炎（乙肝）的肝癌死亡约16．36万人（占45．69％），继发于丙型肝炎（丙肝）的肝癌死亡约13．42万人（占37．48％）；肝癌造成的DALY为4080．40万人年，按照DALY排序，第一位依然是继发于乙肝的肝癌，其次是继发于丙肝的肝癌、其他肝癌、继发于酒精性肝病的肝癌，导致的DALY依次为465．20、339．43、96．43、59．21万人年，男性人群继发于肝病的肝癌DALY均显著高于女性。与1990年相比，肝癌标化死亡葺墨下降25．00％，肝癌DALY绝对值上升16．95％，肝癌的年龄标化DALY率下降33．47％；其巾，继发于丙肝的肝癌疾病负担日趋严重，23年来，其标化死亡率上升106．18％，标化DALY率上升91．68％。分年龄组来看，青壮年和老年人群的肝癌疾病负担最为严重，与1990年相比，肝癌标化DALY率在各个年龄段均呈现下降趋势，下降幅度最大是5～14岁，其中，继发于乙肝的肝癌DALY率在5～14岁年龄段下降幅度为46．37％，而继发于丙肝的肝癌DALY率在各个年龄段均呈上升趋势。结论现阶段肝癌依然是造成严重疾病负担的恶性肿瘤之一，近年来，继发于乙肝的肝癌疾病负担下降，但继发于丙肝的肝癌疾病负担冠著上升，男性人群肝癌疾病负担显著高于女性，开展针对性的防控措施迫在眉睫．．

英文摘要：

[Abstract] Objective To analyze the disease burden of liver cancer in the Chinese population in 1990 and 2013. Methods Data from Global Burden of Diseases 2013 （GBD2013） was used to analyze the disease burden of liver cancer in China. The main outcome measurements would include mortality and disability-adjusted life years （DALY）. Again, GBD global standard population in 2013 was used as the reference population to calculate the age-standardized rate. Related changes on percentage from 1990 to 2013 were calculated to analyze the changing patterns of disease burden for liver cancer in China. Results In 2013, a total of 358 100 people died of liver cancer, with the crude death rate as 25.85/100 000, in China. Number of deaths due to liver cancer secondary to hepatitis B was 163 600 （accounting for 45.69%）. Number of deaths due to liver cancer secondary to hepatitis Cwas 134 200 （accounting for 37.48%） with DALY due to liver cancer appeared as 40.80 million person years. In 2013, the leading causes of DALY related to liver cancer was liver cancer secondary to hepatitis B, followed by liver cancer secondary to hepatitis C, liver cancer secondary to alcohol use, other liver cancers, with related DALYs as 4 652.0, 3 394.3, 964.3 and 592.1 thousands person years, respectively. The disease burdens of liver cancer secondary to various kinds of liver cancer were significantly higher in males than in females. Compared with 1990, the standardized mortality of liver cancer reduced by 25.00%, the DALY attributable to liver cancer increased by 16.95% and the standardized DALY rate attributable to liver cancer reduced by 33.47%. The burden of liver cancer secondary to hepatitis C became more serious and the standardized death rate increased by 106.18%, together with the standardized DALY rate increased by 91.68% in the past 23 years. Disease burden of liver cancer among young adults and the elderly were most serious. When comparing with the data in 1990, the standardized DALY rate showed declining trend in all the